Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) - TA4
| Agency: | DEPT OF DEFENSE |
|---|---|
| State: | Federal |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Posted Date: | Jun 11, 2026 |
| Due Date: | Jun 29, 2026 |
| Solicitation No: | DARPA-SN-26-91 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
Follow
Active
Contract Opportunity
Notice ID
DARPA-SN-26-91
Related Notice
DARPA-PS-26-124
Department/Ind. Agency
DEPT OF DEFENSE
Sub-tier
DEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA)
Office
DEF ADVANCED RESEARCH PROJECTS AGCY
General Information
Classification
Description
Contact Information
History
- Contract Opportunity Type: Special Notice (Original)
- Original Published Date: Jun 11, 2026 06:07 pm EDT
- Original Response Date: Jun 29, 2026 03:00 pm EDT
- Inactive Policy: Manual
- Original Inactive Date: Jul 28, 2026
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: AC12 - NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; APPLIED RESEARCH
-
NAICS Code:
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
-
Place of Performance:
The Defense Advanced Research Projects Agency (DARPA) is seeking support for commercialization of technologies to be developed under the upcoming Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) program.
The purpose of this announcement is to notify the community of the RAPIID commercialization goals, initiate dialogue to address program needs, and share the timetable for full proposal submission.
This special notice is released under the current DARPA BTO Office Wide Broad Agency Announcement (BAA) HR001126S0003, titled “Biological Technologies.”
The purpose of this announcement is to notify the community of the RAPIID commercialization goals, initiate dialogue to address program needs, and share the timetable for full proposal submission.
This special notice is released under the current DARPA BTO Office Wide Broad Agency Announcement (BAA) HR001126S0003, titled “Biological Technologies.”
Attachments/Links
Contracting Office Address
- 675 NORTH RANDOLPH STREET
- ARLINGTON , VA 222032114
- USA
Primary Point of Contact
- LCDR Robert Murray, Program Manager, DARPA/BTO
- RAPIID@darpa.mil
Secondary Point of Contact
- Jun 11, 2026 06:07 pm EDTSpecial Notice (Original)
- May 28, 2026 03:37 pm EDT Solicitation (Updated)
Get Government Bids Like This by Email
Receive daily bid alerts that match your keywords, business categories, and target regions.
See Also
Follow ARPA-H Comprehensive Organ System Modeling in Outer Space (COSMOS) Innovative Solutions Opening
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Due by 10/07/2026
Follow Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories Active Contract
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Due by 10/20/2026
Follow RFI for Next Generation Hypersonic Cruise Missiles Active Contract Opportunity Notice ID
DEPT OF DEFENSE
Due by 11/06/2026
Follow N66001-26-R-0030 - Academic Research MAC Active Contract Opportunity Notice ID N6600126R0030 Related
DEPT OF DEFENSE
Due by 10/09/2026
* Disclaimer: This website provides information about bids, requests for proposals (RFPs), or requests for qualifications (RFQs) for convenience only and does not serve as an official public notice. Individuals who wish to respond to or inquire about bids, RFPs, or RFQs should contact the relevant government department directly.